Emerging Trends of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving First-Line Highly Active Antiretroviral Therapy: A Systematic Review and Meta-Analysis | Zendy

Huixin Liu | Zendy; Ye Ma | Zendy; Yingying Su | Zendy; M. Kumi Smith | Zendy; Ying Liu | Zendy; Yantao Jin | Zendy; Hongqiu Gu | Zendy; Jing Wu | Zendy; Lin Zhu | Zendy; Ning Wang | Zendy

Open Access

Emerging Trends of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving First-Line Highly Active Antiretroviral Therapy: A Systematic Review and Meta-Analysis

Author(s) -

Huixin Liu,

Ye Ma,

Yingying Su,

M. Kumi Smith,

Ying Liu,

Yantao Jin,

Hongqiu Gu,

Jing Wu,

Lin Zhu,

Ning Wang

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu590

Subject(s) - medicine , didanosine , confidence interval , meta analysis , regimen , viral load , drug resistance , hiv drug resistance , antiretroviral therapy , immunology , human immunodeficiency virus (hiv) , biology , microbiology and biotechnology

Highly active antiretroviral therapy (HAART) has led to a dramatic decrease in AIDS-related morbidity and mortality through sustained suppression of human immunodeficiency virus (HIV) replication and reconstitution of the immune response. Settings like China that experienced rapid HAART rollout and relatively limited drug selection face considerable challenges in controlling HIV drug resistance (DR).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research